Proficio Capital Partners LLC Invests $1.55 Million in Solventum Co. (NYSE:SOLV)

Proficio Capital Partners LLC acquired a new position in shares of Solventum Co. (NYSE:SOLV - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 23,385 shares of the company's stock, valued at approximately $1,545,000.

A number of other hedge funds have also bought and sold shares of the company. Modus Advisors LLC purchased a new position in shares of Solventum during the 4th quarter worth about $25,000. Stonebridge Financial Group LLC purchased a new position in shares of Solventum during the fourth quarter valued at approximately $26,000. Crews Bank & Trust bought a new position in shares of Solventum during the fourth quarter valued at approximately $32,000. True Wealth Design LLC raised its holdings in shares of Solventum by 23,550.0% in the third quarter. True Wealth Design LLC now owns 473 shares of the company's stock worth $33,000 after buying an additional 471 shares during the period. Finally, Prospera Private Wealth LLC bought a new stake in shares of Solventum during the 3rd quarter worth approximately $35,000.

Analyst Ratings Changes

A number of analysts have weighed in on SOLV shares. Piper Sandler increased their target price on Solventum from $75.00 to $84.00 and gave the stock a "neutral" rating in a research note on Friday, February 28th. Mizuho lifted their price objective on shares of Solventum from $70.00 to $82.00 and gave the company a "neutral" rating in a report on Monday, March 3rd. Morgan Stanley boosted their price objective on shares of Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a research report on Wednesday, March 5th. Bank of America lifted their price target on shares of Solventum from $80.00 to $85.00 and gave the company a "neutral" rating in a research note on Wednesday, February 26th. Finally, The Goldman Sachs Group increased their price objective on Solventum from $63.00 to $71.00 and gave the stock a "sell" rating in a research note on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, Solventum currently has an average rating of "Hold" and an average target price of $79.86.

Remove Ads

Solventum Stock Up 0.4 %

NYSE SOLV traded up $0.27 during midday trading on Monday, hitting $74.24. 1,110,475 shares of the company traded hands, compared to its average volume of 1,428,233. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $85.92. The company's 50-day simple moving average is $75.17 and its 200-day simple moving average is $71.61. The company has a market cap of $12.84 billion and a PE ratio of 27.00. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.